Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0016020 | membrane | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A4HIJ8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.599 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.405 |
CLV_PCSK_FUR_1 | 23 | 27 | PF00082 | 0.331 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.396 |
CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.457 |
DOC_MAPK_gen_1 | 23 | 33 | PF00069 | 0.354 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 133 | 137 | PF00917 | 0.450 |
LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.354 |
LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.371 |
LIG_APCC_ABBA_1 | 31 | 36 | PF00400 | 0.352 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.466 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.468 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.629 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.276 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.345 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.391 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.588 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.475 |
LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.392 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.409 |
LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.337 |
LIG_SH2_STAT3 | 64 | 67 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.349 |
LIG_SUMO_SIM_anti_2 | 70 | 78 | PF11976 | 0.429 |
LIG_TYR_ITIM | 19 | 24 | PF00017 | 0.267 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.477 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.698 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.421 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.474 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.386 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.591 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.394 |
MOD_PIKK_1 | 139 | 145 | PF00454 | 0.466 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.465 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.473 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.384 |
MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.477 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.382 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.604 |
MOD_SUMO_rev_2 | 104 | 112 | PF00179 | 0.392 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.328 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.347 |
TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.388 |
TRG_NLS_MonoExtC_3 | 24 | 29 | PF00514 | 0.450 |
TRG_NLS_MonoExtN_4 | 23 | 29 | PF00514 | 0.448 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5G5 | Leptomonas seymouri | 69% | 100% |
A0A3Q8IS54 | Leishmania donovani | 77% | 100% |
A0A3R7LZP3 | Trypanosoma rangeli | 52% | 99% |
A4I5U2 | Leishmania infantum | 77% | 100% |
E9B137 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q4Q729 | Leishmania major | 74% | 100% |
V5DP06 | Trypanosoma cruzi | 47% | 99% |